" In people, perhaps the most well known isoprenoid is cholesterol that is effectively controlled with statin drugs."
Washington, July 25 - Researchers have uncovered a way the malaria parasite becomes resistant to a key clinical trial drug.

The parasite that causes malaria makes a class of molecules called isoprenoids.

These play multiple roles in keeping organisms healthy, whether plants, animals or bacteria.

In malaria, the investigational drug fosmidomycin blocks isoprenoid synthesis, killing the parasite. But over time, the drug often becomes less effective.

In trials testing fosmidomycin, the malaria parasite returned in more than half the children by the end of the study, said Audrey R. Odom, an assistant professor of pediatrics at Washington University's school of medicine in St. Louis.

We wanted to know how the parasite is getting around the drug. How can it manage to live even though the drug is suppressing these compounds that are necessary for life? Odom added.

Fosmidomycin, an antibiotic, is being evaluated against malaria in phase 3 clinical trials in combination with other anti-malarial drugs.

According to Odom, isoprenoid synthesis is an attractive drug target not just for malaria but for tuberculosis and other bacterial infections.

Inhibiting isoprenoid manufacturing in malaria, bacteria or tuberculosis would leave the human pathways safely alone.

In people, perhaps the most well known isoprenoid is cholesterol that is effectively controlled with statin drugs.

The study appeared in the journal Nature Communications.


comments powered by Disqus
Read more on:
 

PERMALINK

http://www.nerve.in/news:2535002390994
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for Americas


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.